3.02
price down icon0.98%   -0.03
after-market Handel nachbörslich: 3.02
loading
Schlusskurs vom Vortag:
$3.05
Offen:
$3.01
24-Stunden-Volumen:
277.62K
Relative Volume:
0.77
Marktkapitalisierung:
$50.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.73M
KGV:
-2.1843
EPS:
-1.3826
Netto-Cashflow:
$-10.37M
1W Leistung:
-7.08%
1M Leistung:
+23.27%
6M Leistung:
+5.59%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$2.95
$3.09
1-Wochen-Bereich:
Value
$2.95
$3.35
52-Wochen-Spanne:
Value
$1.80
$8.94

Medicus Pharma Ltd Stock (MDCX) Company Profile

Name
Firmenname
Medicus Pharma Ltd
Name
Telefon
610-540-7515
Name
Adresse
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MDCX's Discussions on Twitter

Vergleichen Sie MDCX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MDCX
Medicus Pharma Ltd
3.02 50.58M 0 -11.73M -10.37M -1.3826
Drug Manufacturers - General icon
LLY
Lilly Eli Co
805.43 717.19B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
169.56 404.05B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
190.83 330.51B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
117.46 228.37B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
70.73 311.17B 43.59B 15.04B 10.74B 3.3766

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

pulisher
12:24 PM

Should I buy Medicus Pharma Ltd. stock before earningsHigh-velocity gains - jammulinksnews.com

12:24 PM
pulisher
12:05 PM

What analysts say about Medicus Pharma Ltd. stock outlookUnstoppable trading performance - jammulinksnews.com

12:05 PM
pulisher
02:16 AM

Is Medicus Pharma Ltd. a good long term investmentUnprecedented profit potential - jammulinksnews.com

02:16 AM
pulisher
Jul 23, 2025

What analysts say about Medicus Pharma Ltd. Equity Warrant stockExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Medicus Pharma shareholders approve new board members and FDA submission for Skin Cancer therapy - Proactive financial news

Jul 23, 2025
pulisher
Jul 23, 2025

Medicus Pharma Ltd. Equity Warrant Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Medicus Pharma Ltd. Strengthens Board with New Appointments - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders - Newsfile

Jul 23, 2025
pulisher
Jul 23, 2025

TVA Group: Top 10 Undervalued MediaDiversified Industry Stocks (TVA-B) - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Medicus Pharma Ltd. Stock Analysis and ForecastSpectacular growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Medicus Pharma Ltd. stock priceRapid-fire capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Medicus Pharma Ltd. Equity Warrant a good long term investmentExponential wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Medicus Pharma Ltd. stockStrongest growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Medicus Pharma Ltd. Equity Warrant stock priceUnmatched profit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Medicus Pharma Ltd. Expands Clinical Trials and Announces Strategic Acquisition - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025 - Yahoo Home

Jul 21, 2025
pulisher
Jul 21, 2025

Medicus CEO to present at BTIG Virtual Biotech Conference on July 30 - Proactive financial news

Jul 21, 2025
pulisher
Jul 17, 2025

What makes Medicus Pharma Ltd. stock price move sharplyProtected Capital Trading Plan - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Pipeline Presents - openPR.com

Jul 16, 2025

Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$50.13
price down icon 0.06%
$113.20
price down icon 0.32%
drug_manufacturers_general PFE
$25.35
price down icon 0.04%
$308.55
price down icon 0.22%
drug_manufacturers_general MRK
$84.11
price up icon 0.15%
drug_manufacturers_general NVO
$70.73
price up icon 1.00%
Kapitalisierung:     |  Volumen (24h):